Summary
Mary is an Honorary Research Associate at the Centre for Haematology, Imperial College London. Her Research interest falls mainly in the field of molecular quantification and minimal residual disease monitoring in haematological malignancies in addition to personalized medicine and molecular testing in general. Mary completed her PhD at Imperial in 2015 with the title ‘Molecular Pathology and Genomics Medicine’and moved on to become a junior investigator in the field of precision medicine. Before joining Imperial, Mary studied at Queen Mary University of London where she completed an MSc degree in Cancer Therapeutics
Publications
Journals
Alikian M, Whale AS, Akiki S, et al., 2017, RT-qPCR and RT-Digital PCR: a comparison of different platforms for the evaluation of residual disease in chronic myeloid leukemia, Clinical Chemistry, Vol:63, ISSN:1530-8561, Pages:525-531
Alikian MA, Peter Ellery PE, Martin Forbes MF, et al., 2016, Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia Patients, Journal of Molecular Diagnostics, Vol:18, ISSN:1943-7811, Pages:176-189